Early diagnosis of PRS and application of contemporary therapies may hopefully bring PRKAG2 cardiomyopathy towards the low mortality rates and good quality of life that have been reached over the years for sarcomeric HCM. The gene discussed is PRKAG2; the disease is cardiomyopathy.